High Tide Inc. (HITI) vs Keros Therapeutics, Inc. (KROS)
A side-by-side comparison of High Tide Inc. and Keros Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HITI
High Tide Inc.
$2.70HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
KROS
Keros Therapeutics, Inc.
$11.19HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Total return — HITI vs KROS
growth of $100 · dividends reinvested · last 6yHITI +112.1% (+13.4%/yr)KROS -42.6% (-8.8%/yr)HITI compounded faster over this window
HITI KROS
HITI vs KROS: by the numbers
- •HITI is the larger company ($237M vs $222M market cap).
- •Both run net losses; HITI's is the smaller (-4.52% vs -553.88% net margin).
- •KROS grew revenue faster over the past five years (172.50% vs 33.84% CAGR).
Metrics side by side
Valuation
| Metric | HITI | KROS |
|---|---|---|
| P/S ratio | 0.45 | 14.78 |
| P/B ratio | 3.16 | 0.85 |
| EV / EBITDA | 12.78 | N/A |
| FCF yield | 4.84% | N/A |
Profitability
| Metric | HITI | KROS |
|---|---|---|
| Gross margin | 25.85% | 94.68% |
| Operating margin | 0.56% | 28.94% |
| Net margin | -4.52% | -553.88% |
| ROE | -31.55% | -31.70% |
| ROIC | 1.38% | -36.49% |
Growth (annualized)
| Metric | HITI | KROS |
|---|---|---|
| Revenue CAGR (5Y) | 33.84% | 172.50% |
| Total return CAGR (5Y) | -14.29% | -21.98% |
Frequently asked
- Which has grown faster, HITI or KROS?
- Over the past five years, KROS grew revenue faster — HITI at a 33.84% CAGR versus KROS at 172.50%.
- How have HITI and KROS total returns compared?
- Over the past 5 years, HITI delivered -14.29% and KROS delivered -21.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
High Tide ROEKeros Therapeutics ROEHigh Tide operating marginKeros Therapeutics operating marginHigh Tide revenue growthKeros Therapeutics revenue growthHigh Tide free cash flowKeros Therapeutics free cash flow
High Tide & Keros Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.